New monthly HIV prevention pill passes heart safety check in early trial
NCT ID NCT07063238
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a higher-than-normal dose of MK-8527, a once-monthly pill to prevent HIV infection, affects heart rhythm. It involved 42 healthy adults and compared the drug to a placebo and an active control. The goal was to ensure the drug is safe for the heart before moving to larger studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hassman Research Institute Marlton Site ( Site 0001)
Marlton, New Jersey, 08053, United States